Souders Financial Advisors Acadia Pharmaceuticals Inc Transaction History

Souders Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $216,648 - $476,158	-8,659 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$41.04 - $56.79 $12,353 - $17,093	301 Added 3.6%	8,659 $463,000
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $19,120 - $29,925	525 Added 6.7%	8,358 $410,000
Q2 2020 Aug 11, 2020	BUY	$39.26 - $52.73 $77,970 - $104,721	1,986 Added 33.97%	7,833 $380,000
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $185,057 - $274,048	5,847 New	5,847 $247,000

298

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.61B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Souders Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Souders Financial Advisors with notifications on news.